Welspun Corp Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:29 pm

Quick Insight

Welspun Corp Ltd, with a market capitalization of ₹23,046 Cr. and a P/E ratio of 14.2, is showing strength in its financial performance. The company's Return on Equity (ROE) stands at a healthy 18.5%, while the Return on Capital Employed (ROCE) is even more impressive at 21.2%. With a Net Profit of ₹1,902 Cr. and a solid Operating Profit Margin (OPM) of 15%, Welspun Corp is demonstrating efficiency and profitability in its operations. The company's Promoter holding at 50.00% indicates a strong alignment of interests, while the Debt-to-Equity ratio of 3.06x suggests a prudent capital structure. Overall, Welspun Corp's financial metrics paint a positive picture, making it a potentially attractive investment opportunity in the steel industry.

Competitors of Welspun Corp Ltd

All Competitor Stocks of Welspun Corp Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:10 am

Below is a detailed analysis of the quarterly data for Welspun Corp Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,551.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,925.00 Cr. (Mar 2025) to 3,551.00 Cr., marking a decrease of 374.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,026.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,465.00 Cr. (Mar 2025) to 3,026.00 Cr., marking a decrease of 439.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 525.00 Cr.. The value appears strong and on an upward trend. It has increased from 460.00 Cr. (Mar 2025) to 525.00 Cr., marking an increase of 65.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 15.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 570.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 486.00 Cr..
• For Interest, as of Jun 2025, the value is 63.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 88.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 25.00 Cr..
• For Depreciation, as of Jun 2025, the value is 85.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 87.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 461.00 Cr.. The value appears to be declining and may need further review. It has decreased from 855.00 Cr. (Mar 2025) to 461.00 Cr., marking a decrease of 394.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 18.00% (Mar 2025) to 24.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 349.00 Cr.. The value appears to be declining and may need further review. It has decreased from 699.00 Cr. (Mar 2025) to 349.00 Cr., marking a decrease of 350.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.31. The value appears to be declining and may need further review. It has decreased from 26.62 (Mar 2025) to 13.31, marking a decrease of 13.31.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:44 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for Welspun Corp Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 131.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 131.00 Cr..
• For Reserves, as of Mar 2025, the value is 7,313.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,467.00 Cr. (Mar 2024) to 7,313.00 Cr., marking an increase of 1,846.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,122.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,967.00 Cr. (Mar 2024) to 1,122.00 Cr., marking a decrease of 845.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 6,635.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,249.00 Cr. (Mar 2024) to 6,635.00 Cr., marking an increase of 2,386.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 15,201.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,813.00 Cr. (Mar 2024) to 15,201.00 Cr., marking an increase of 3,388.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4,707.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,800.00 Cr. (Mar 2024) to 4,707.00 Cr., marking a decrease of 93.00 Cr..
• For CWIP, as of Mar 2025, the value is 787.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2024) to 787.00 Cr., marking an increase of 700.00 Cr..
• For Investments, as of Mar 2025, the value is 1,402.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,100.00 Cr. (Mar 2024) to 1,402.00 Cr., marking an increase of 302.00 Cr..
• For Other Assets, as of Mar 2025, the value is 8,306.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,827.00 Cr. (Mar 2024) to 8,306.00 Cr., marking an increase of 2,479.00 Cr..
• For Total Assets, as of Mar 2025, the value is 15,201.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,813.00 Cr. (Mar 2024) to 15,201.00 Cr., marking an increase of 3,388.00 Cr..

Notably, the Reserves (7,313.00 Cr.) exceed the Borrowings (1,122.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Welspun Corp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 72.80. This value is within the healthy range. It has increased from 42.45 (Mar 24) to 72.80, marking an increase of 30.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 72.44. This value is within the healthy range. It has increased from 42.32 (Mar 24) to 72.44, marking an increase of 30.12.
• For Cash EPS (Rs.), as of Mar 25, the value is 62.68. This value is within the healthy range. It has increased from 46.70 (Mar 24) to 62.68, marking an increase of 15.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 284.13. It has increased from 213.92 (Mar 24) to 284.13, marking an increase of 70.21.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 284.13. It has increased from 213.92 (Mar 24) to 284.13, marking an increase of 70.21.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 532.80. It has decreased from 662.68 (Mar 24) to 532.80, marking a decrease of 129.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 70.82. This value is within the healthy range. It has increased from 68.94 (Mar 24) to 70.82, marking an increase of 1.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 57.44. This value is within the healthy range. It has increased from 55.65 (Mar 24) to 57.44, marking an increase of 1.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 63.01. This value is within the healthy range. It has increased from 44.01 (Mar 24) to 63.01, marking an increase of 19.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 49.30. This value is within the healthy range. It has increased from 33.41 (Mar 24) to 49.30, marking an increase of 15.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 72.73. This value is within the healthy range. It has increased from 42.44 (Mar 24) to 72.73, marking an increase of 30.29.
• For PBDIT Margin (%), as of Mar 25, the value is 13.29. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 13.29, marking an increase of 2.89.
• For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 8.39 (Mar 24) to 10.78, marking an increase of 2.39.
• For PBT Margin (%), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 6.64 (Mar 24) to 11.82, marking an increase of 5.18.
• For Net Profit Margin (%), as of Mar 25, the value is 9.25. This value is within the healthy range. It has increased from 5.04 (Mar 24) to 9.25, marking an increase of 4.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.65. This value is within the healthy range. It has increased from 6.40 (Mar 24) to 13.65, marking an increase of 7.25.
• For Return on Networth / Equity (%), as of Mar 25, the value is 25.59. This value is within the healthy range. It has increased from 19.83 (Mar 24) to 25.59, marking an increase of 5.76.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.90. This value is within the healthy range. It has decreased from 18.49 (Mar 24) to 16.90, marking a decrease of 1.59.
• For Return On Assets (%), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 12.52, marking an increase of 3.15.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.28 (Mar 24) to 0.06, marking a decrease of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.12, marking a decrease of 0.21.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has decreased from 1.28 (Mar 24) to 1.03, marking a decrease of 0.25.
• For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.53 (Mar 24) to 1.33, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.66, marking a decrease of 0.28.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 4. It has increased from 2.66 (Mar 24) to 2.93, marking an increase of 0.27.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.77 (Mar 24) to 0.00, marking a decrease of 11.77.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.96 (Mar 24) to 0.00, marking a decrease of 8.96.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.23 (Mar 24) to 0.00, marking a decrease of 88.23.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.04 (Mar 24) to 0.00, marking a decrease of 91.04.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.81. This value is within the healthy range. It has decreased from 5.93 (Mar 24) to 5.81, marking a decrease of 0.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.59. This value is within the healthy range. It has decreased from 3.87 (Mar 24) to 3.59, marking a decrease of 0.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 22,725.18. It has increased from 14,454.64 (Mar 24) to 22,725.18, marking an increase of 8,270.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.83 (Mar 24) to 1.63, marking an increase of 0.80.
• For EV / EBITDA (X), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 8.01 (Mar 24) to 12.23, marking an increase of 4.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 1.63, marking an increase of 0.86.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.22 (Mar 24) to 0.00, marking a decrease of 88.22.
• For Price / BV (X), as of Mar 25, the value is 3.06. This value exceeds the healthy maximum of 3. It has increased from 2.41 (Mar 24) to 3.06, marking an increase of 0.65.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 1.63, marking an increase of 0.86.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness